943776-95-2

Upstream product

• 38818-50-7 4-chloro-3-nitro-benzoyl chloride 
• 106-40-1 4-bromo-aniline 
• 5782-69-4 6-isopropyl-2-oxo-1,2-dihydropyridine-3-carbonitrile 
• 55793-14-1 4-methyl-3-oxo-pentanal; sodium enolate 
• 943776-93-0 {4-[4-(4-bromo-phenylcarbamoyl)-2-nitro-phenoxy]-phenyl}-carbamic acid 2,2,2-trichloroethyl ester 
• 943772-71-2 4-(4-amino-phenoxy)-N-(4-bromo-phenyl)-3-nitro-benzamide 
• 329941-08-4 N-(4-bromo-phenyl)-4-chloro-3-nitro-benzamide 
• 943771-01-5 2-amino-6-isopropyl-nicotinonitrile 
• 943771-00-4 2-bromo-6-isopropyl-nicotinonitrile 
• 563-80-4 3-methyl-butan-2-one 
• 943771-02-6 N'-(3-cyano-6-isopropyl-pyridin-2-yl)-N,N-dimethyl-formamidine 
• 943776-94-1 {4-[2-amino-4-(4-bromo-phenylcarbamoyl)-phenoxy]-phenyl}-carbamic acid 2,2,2-trichloro-ethyl ester 

Downstream Products

• 943776-92-9 morpholine-4-carboxylic acid {4-[4-(4-bromo-phenylcarbamoyl)-2-(7-isopropyl-pyrido[2,3-d]pyrimidin-4-ylamino)-phenoxy]-phenyl}-amide trifluoroacetate 

Relevant academic research and scientific papers

ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ( HCV ) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, coformulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.